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Abstract - Introduction: Young onset psychosis has poor prognosis, and inborn errors of metabolism (IEM) can be easily 
missed. There is scarce information regarding IEM and young onset psychosis in Malaysia. Case Report: A 15-year-old Ma-
lay girl presented at the age of 8 years with a history of intellectual disability and neuro-regression, subsequently devel-
oping psychotic and obsessive-compulsive symptoms several years later. Organic workup revealed elevated lactate levels. 
Urine organic acid chromatogram revealed a moderate peak of lactate however most other investigations were normal. 
As MRI brain is normal and there are no neurological signs it appears less likely there is an underlying IEM-related aetiol-
ogy for psychosis. Discussion: Various IEMs can be related to psychosis however the incidence is very low and quality of 
evidence is poor. Thus, any psychiatric presentation, particularly with suggestive clinical signs, should warrant an organic 
(including IEM) workup since these causes are potentially reversible with supplementation.
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Introduction
Young onset psychosis has a very poor 
prognosis [1], correlated with higher social 
disability scores [2]. However, any associated 
atypical or organic symptoms should prompt 
a search for organic aetiologies. This case re-
port discusses a rare but interesting possibility 
of  psychosis secondary to an inborn error of  
metabolism (IEM). It also aims to supplement 
scarce information regarding IEM and young 
onset psychosis, as it is scant both in the Ma-
laysian setting and in the world. 
Case Report
Ms NZ is a 15-year-old Malay girl who ini-
tially presented aged eight as a referral from a 
general practitioner to a psychiatrist. She pre-
sented with increasingly poor academic prog-
ress that year, accompanied by new onset set-
backs in ability to read and write, which were 
also associated with hyperactivity and inatten-
tion, especially noticeable in school. According 
to history elicited from her parents, prior to 
the age of  eight, she was able to construct age-
appropriate sentences and was able to perform 
all activities of  daily living including feeding, 
toileting, and self-care. Her gross and fine mo-
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tor skills prior to the age of  8 had been slightly 
delayed, but she had been able to attend con-
ventional kindergarten previously without be-
ing referred to special education, and she had 
previously exhibited appropriate social cogni-
tions at pre-school. In terms of  cognitive abili-
ties, she was able to draw up to age prior to the 
age of  eight. In terms of  reading and writing, 
she was able to recognise words and write sen-
tences, albeit a little slowly, but it had not been 
grossly impaired previously.
A year later, she became increasingly para-
noid and felt she was being watched. Her para-
noia extended to small animals e.g. cats and 
the sounds of  vacuum cleaners. She was thus 
frequently anxious and worried resulting in 
school refusal. There were no perceptual ab-
normalities, seizures, abnormal movements or 
self-mutilations. 
Over the subsequent 3 years, she showed 
signs of  neuro-regression. She was previously 
toilet trained but started soiling herself. She 
also could not manage activities of  daily living 
e.g. bathing, changing clothes etc, where pre-
viously she was able. Her writing deteriorated 
and became unrecognizable. She walked hold-
ing on to walls and furniture and her move-
ments became slow. Otherwise, there were 
no depressive or manic symptoms noted. Her 
parents are unrelated and there is no similar 
family history. Birth history was unremarkable 
and there were no antenatal or postnatal dif-
ficulties or childhood infections. There was 
slight delay in speech and gross motor devel-
opment. 
Physical examination revealed a well-nour-
ished child who was not dysmorphic. She had 
hyperpigmented streaks on her trunk and 
limbs, which followed Blaschko lines. Her gait 
was slow and careful but not broad based nor 
ataxic. Examinations of  other systems were 
normal. Thyroid function tests, full blood 
counts, renal and liver functions were normal. 
She was diagnosed as intellectual disability with 
psychosis based on clinical picture; an IQ test 
was not performed at that time by the treating 
team as she exhibited gross deficiencies. She 
was commenced on quetiapine and it resulted 
in an improvement of  her movements.
A year later, she began demonstrating well-
formed auditory hallucinations and strong 
persecutory delusions. Speech was also in-
creasingly disorganised with use of  neolo-
gisms and echolalia. There was no thought 
alienation or any perceptual disturbances in 
other modalities. Repetitive behaviours also 
evolved, related to checking water pipes, fre-
quently washing her hands, not eating certain 
kinds of  food and changing clothes repetitive-
ly. Her diagnosis was revised to schizophrenia 
with obsessive-compulsive symptoms and un-
derlying intellectual disability. She was trialled 
on multiple antipsychotics, but was sensitive 
to many (olanzapine, risperidone, haloperidol, 
and chlorpromazine). She developed multiple 
extrapyramidal side effects to risperidone, hal-
operidol, and chlorpromazine on low doses, 
including dystonia and akathisia, and devel-
oped metabolic syndrome while on olanzap-
ine.
Her behaviour became increasingly un-
manageable, warranting a week of  hospitali-
sation. Despite augmentation of  quetiapine 
with aripiprazole, sodium valproate, and es-
citalopram, her symptoms appeared to be 
poorly controlled. Moreover, her behaviour 
remained difficult, with tantrums and sud-
den episodes of  verbal aggression. Upon fur-
ther investigating her young-onset psychosis, 
MRI Brain was normal. However, inciden-
tally her lactate was elevated (5.8mmol/L), 
with a mildly elevated Alanine (592 umol/L) 
and Glycine (307 umol/L). With further help 
from the genetics team, urine organic acid 
chromatogram revealed a moderate peak of  
lactate, with a small but significant peak of  
glycolate and oxalate. No diagnostic pattern 
could be inferred. Most secondary screenings 
were normal (Table 1).
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Juvenile metachromatic leukodystrophy 
needed to be ruled out as it occasionally pres-
ents with behavioural changes and psychosis 
before mental deterioration. However, this 
diagnosis is usually accompanied by MRI 
changes. EEG testing was therefore arranged 
to investigate for other causes.
Discussion
The overall incidence of  IEMs has been 
estimated to be approximately 40 cases per 
100,000 live births [3]. A number of  adult-
onset IEMs are associated with psychosis: 
homocysteine metabolism diseases, urea cy-
cle disorders, porphyria, Wilson disease, ce-
rebrotendinous xanthomatosis and Niemann-
Pick disease type C [4]. A pioneering 2014 
Table 1. Results of  performed investigations
Investigation Result Normal Values
OTC (Ornithine Carbamoyltransferase) 
Gene Testing
No mutation detected
LSD (Lysosyme Storage Disease) Screening All negative
Urine Mucopolysaccharides Normal
Serum copper Normal 11-22 umol/L
Ceruloplasmin Normal Male: 0.15 – 0.30 g/L
Female: 0.16 – 0.45g/L
Ammonia Normal Male: 16 – 60 umol/L
Female: 11-51 umol/L
Phytanic acid/VLC (Very Long Chain) 
fatty acid
Normal < 0.2 mg/dL
Congenital disorder of  glycosylation screen Normal
Orotic, uracil, pseudourine, hypoxanthine, 
xanthine, thymine
Normal Orotic: <2 nmol/mL




Uric acid 789 (Mildly elevated) 150 – 500 umol/L
Lactate 5.8 mmol/L (High) < 2.2 mmol/L
Plasma amino acids Non-specific elevation of  
glutamate and ornithine
Low levels of  methionine, 
leucine, phenylalanine, few 
EFA (most likely due to 
poor oral intake
Glutamate: 32 – 140 umol/L
Ornithine: 44 – 90 umol/L
Methionine: 13 – 30 umol/L
Leucine: 70 – 170 umol/L
Phenylalanine: 26 – 86 umol/L
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systematic review demonstrated evidence re-
garding prevalence of  psychosis in IEMs was 
of  poor quality due to their rarity; only 611 
cases were identified in the literature review 
stretching from 1967-2012 [5]. Sedel and as-
sociates (2007) presented an alternative tripar-
tite IEM classification according to psychiatric 
signs at onset. Group 1 present with emer-
gencies, manifesting with recurrent bouts of  
confusion. Group 2 IEMs are associated with 
chronic psychiatric symptoms arising in ado-
lescence. Group 3 contains IEMs presenting 
as mild mental retardation and late-onset be-
havioural or personality changes [4]. 
Ms NZ’s changes appear to fall more into 
Group 2 IEMs. This group includes homocys-
tinuria [6], Wilson disease [7], adrenoleukodys-
trophy [8] and some lysosomal disorders [9]. 
In the case of  Ms NZ, Wilson’s is excluded 
by clinical findings and copper/ceruloplas-
min results, whereas leukodystrophy is usu-
ally accompanied by MRI evidence. There is 
no characteristic elevation of  methionine and 
no presence of  homocysteine that should be 
present in a homocystinuria. In addition, a 
solely raised lactate level is not suggestive of  
any IEM related to a psychiatric presentation. 
However, there are associations between ele-
vated lactate levels and schizophrenia, both in 
post-mortem and pre-clinical settings [10,11]. 
There is also increasingly robust evidence sug-
gesting lactate related abnormalities may un-
derpin cognitive dysfunction as well [12]. Re-
cent evidence from domiciliary settings also 
suggest extant relationships between lactate 
levels and intellectual disability [13].
A general diagnostic strategy is suggested 
in these cases [13,14]. IEMs are usually sus-
pected where there is a family history; if  there 
are clinical signs triggered by conditions in-
volving increased protein catabolism, e.g. fe-
ver, food intake, surgery or prolonged fasting; 
or if  there are signs of  a possibly more dif-
fuse clinical picture. This includes neurologi-
cal signs of  cognitive and motor dysfunction, 
as well as systemic signs, e.g. skin, ophthalmo-
logical and visceral signs.
Conclusion
The lack of  dysmorphia, organomegaly 
and neurological signs coupled with a normal 
MRI brain mean the lactate finding is most 
probably not related to an IEM in this case. 
Nevertheless, this is a reminder that any psy-
chiatric presentation, particularly with any 
family history or suggestive clinical signs, can 
be linked to a rare IEM, especially since some 
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Slučaj potencijalne prirođene greške metabolizma kao uzroka 
psihoze s ranim početkom
Sažetak - Uvod: Psihoza ranog početka ima lošu prognozu, a prirođene greške metabolizma (PGM) mogu 
se lako previdjeti. Informacije o PGM-u i psihozi kod mladih u Maleziji su oskudne. Prikaz slučaja: Petnae-
stogodišnja Malezijska djevojčica prezentirala se u dobi od 8 godina s poviješću intelektualnog invaliditeta i 
neuroregresije, nakon čega su se nekoliko godina kasnije razvili psihotični i opsesivno-kompulzivni simptomi. 
Organska obrada otkrila je povišenu razinu laktata. Kromatogram organske kiseline u urinu otkrio je umjereni 
porast laktata, no većina ostalih nalaza bila je u granicama normale. Kako je MRI mozga bio uredan i nije bilo 
neuroloških ispada, čini se manje vjerojatnim da je u podlozi psihoze bila PGM kao etiološki čimbenik. Ra-
sprava: Različite PGM mogu se povezati s psihozom, ali učestalost je vrlo niska, a kvaliteta dokaza loša. Stoga 
bi svaka psihijatrijska klinička slika, posebno sa sugestivnim kliničkim znakovima, trebala uključiti organsku 
obradu (uključujući PGM) jer su ti uzroci potencijalno reverzibilni upotrebom suplemenata. 
Ključne riječi: psihoza; urođena pogreška metabolizma; organski
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